Steven Cohen's HUM Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 98,491 shares of Humana Inc. (HUM) worth $39.12 M, representing 0.04% of the portfolio. First purchased in 2014-Q4, this long-term strategic position has been held for 44 quarters.
Based on 13F filings since 2013, Steven Cohen has maintained a long-term strategic position in HUM, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2019, adding 436,034 shares. Largest reduction occurred in Q3 2024, reducing 489,217 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Humana (HUM) Holding Value Over Time
Track share changes against reported price movement
Quarterly Humana (HUM) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +98,491 | New Buy | 98,491 | $397.22 |
| Q4 2025 | -62,724 | Sold Out | 0 | $0.00 |
| Q3 2025 | -374,074 | Reduce 85.64% | 62,724 | $260.17 |
| Q2 2025 | +288,682 | Add 194.90% | 436,798 | $244.48 |
| Q1 2025 | +73,264 | Add 97.88% | 148,116 | $264.60 |
| Q4 2024 | +74,852 | New Buy | 74,852 | $253.71 |
| Q3 2024 | -489,217 | Sold Out | 0 | $0.00 |
| Q2 2024 | +362,194 | Add 285.14% | 489,217 | $373.65 |
| Q1 2024 | -93,962 | Reduce 42.52% | 127,023 | $346.72 |
| Q4 2023 | -39,318 | Reduce 15.10% | 220,985 | $457.81 |
| Q3 2023 | +259,590 | Add 36408.13% | 260,303 | $486.52 |
| Q2 2023 | -188,366 | Reduce 99.62% | 713 | $447.13 |
| Q1 2023 | +189,079 | New Buy | 189,079 | $485.46 |
| Q4 2022 | -72,889 | Sold Out | 0 | $0.00 |
| Q3 2022 | -301,830 | Reduce 80.55% | 72,889 | $485.19 |
| Q2 2022 | +116,519 | Add 45.13% | 374,719 | $468.07 |
| Q1 2022 | +251,200 | Add 3588.57% | 258,200 | $435.17 |
| Q4 2021 | -58,300 | Reduce 89.28% | 7,000 | $463.86 |
| Q3 2021 | -29,350 | Reduce 31.01% | 65,300 | $389.14 |
| Q2 2021 | -41,677 | Reduce 30.57% | 94,650 | $442.72 |
| Q1 2021 | +52,527 | Add 62.68% | 136,327 | $419.25 |
| Q4 2020 | +14,337 | Add 20.64% | 83,800 | $410.27 |
| Q3 2020 | -19,508 | Reduce 21.93% | 69,463 | $413.89 |
| Q2 2020 | +88,971 | New Buy | 88,971 | $387.76 |
| Q1 2020 | -61,770 | Sold Out | 0 | $0.00 |
| Q4 2019 | -144,321 | Reduce 70.03% | 61,770 | $366.52 |
| Q3 2019 | -229,943 | Reduce 52.74% | 206,091 | $255.67 |
| Q2 2019 | +436,034 | New Buy | 436,034 | $265.30 |
| Q4 2018 | -15,955 | Sold Out | 0 | $0.00 |
| Q3 2018 | -140,645 | Reduce 89.81% | 15,955 | $338.51 |
| Q2 2018 | +156,600 | New Buy | 156,600 | $297.63 |
| Q1 2018 | -162,669 | Sold Out | 0 | $0.00 |
| Q4 2017 | +162,669 | New Buy | 162,669 | $248.07 |
| Q3 2017 | -70,900 | Sold Out | 0 | $0.00 |
| Q2 2017 | -140,228 | Reduce 66.42% | 70,900 | $240.62 |
| Q1 2017 | +185,428 | Add 721.51% | 211,128 | $206.14 |
| Q4 2016 | -7,000 | Reduce 21.41% | 25,700 | $204.05 |
| Q3 2016 | +32,700 | New Buy | 32,700 | $176.88 |
| Q2 2016 | -36,400 | Sold Out | 0 | $0.00 |
| Q1 2016 | +36,400 | New Buy | 36,400 | $182.94 |
| Q3 2015 | -230,200 | Sold Out | 0 | $0.00 |
| Q2 2015 | +199,100 | Add 640.19% | 230,200 | $191.28 |
| Q1 2015 | -20,400 | Reduce 39.61% | 31,100 | $178.01 |
| Q4 2014 | +51,500 | New Buy | 51,500 | $143.63 |
Steven Cohen's Humana Investment FAQs
Steven Cohen first purchased Humana Inc. (HUM) in Q4 2014, acquiring 51,500 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Humana Inc. (HUM) for 44 quarters since Q4 2014.
Steven Cohen's largest addition to Humana Inc. (HUM) was in Q2 2019, adding 436,034 shares worth $115.68 M.
According to the latest 13F filing for Q2 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 98,491 shares of Humana Inc. (HUM), valued at approximately $39.12 M.
As of the Q2 2026 filing, Humana Inc. (HUM) represents approximately 0.04% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Humana Inc. (HUM) was 489,217 shares, as reported at the end of Q2 2024.